ArticleBMC biotechnology2015

High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo.

Xuemei Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.